Business
AsymBio Establishes Integrated Technology Platforms Spanning the Full Biopharmaceutical Development Lifecycle
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, integrated workflows for client programs from early development to commercial manufacturing.
About this update from Asymchem Laboratories (tianjin) Co., Ltd. Class A
[{"type":"text","content":"SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full biopharmaceutical development lifecycle. Through its end-to-end service capabilities, the company provides streamlined, integrated workflows for client programs from early development to commercial manufacturing.","length":411,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/AsymBio)","displaySize":"","headline":null,"caption":"(PRNewsfoto/AsymBio)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/61ea47027a489819bcfc3796dccf396d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u4hC_yYQOh4sqtgnsrsPLA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/61ea47027a489819bcfc3796dccf396d","width":400,"height":400}},"href":"https://mma.prnewswire.com/media/2888481/AsymBio_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"AsymBio is a technology-driven biopharmaceutical CDMO focused on accelerating innovation and providing integrated development and manufacturing services for clients. Key platforms include:","length":188,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"AmigoCHO™ Cell Line Development Platform — Supports the development of high-titer, high-quality, and stable clones, including cell pool establishment, expansion, clone selection, and stability analysis.","length":202,"tagName":"p"}]},{"val":[{"type":"text","content":"Upstream Process Development Platform — Covers process optimization, process scale-up, and process characterization, supporting workflows from preclinical material preparation and IND/BLA-enabling process development to technology transfer and scale-up. Project timelines can be shortened to as little as 9 weeks.","length":313,"tagName":"p"}]},{"val":[{"type":"text","content":"Downstream Process Development Platform — Designed to shorten process development timelines while supporting higher product purity, reduced impurities, and improved yield, including chromatography process development, filtration process development, tech transfer and scale-up, and process characterization.","length":307,"tagName":"p"}]},{"val":[{"type":"text",...
More updates from Asymchem Laboratories (tianjin) Co., Ltd. Class A